子宫内膜癌、子宫肌瘤或卵巢肿瘤患者的垂体促性腺激素和催乳素。
Pituitary gonadotrophins and prolactin in patients with endometrial cancer, fibroids or ovarian tumours.
作者信息
Ylikorkala O, Kauppila A, Rajala T
出版信息
Br J Obstet Gynaecol. 1979 Nov;86(11):901-4. doi: 10.1111/j.1471-0528.1979.tb10721.x.
The serum levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and, prolactin (PRL) were measured before and after gonadotrophin releasing hormone (GnRH) and thyrotrophin releasing hormone (TRH) stimulation in 17 patients with endometrial cancer, in 15 patients with uterine fibroids, in 11 patients with ovarian cystadenomas or cancer and in 14 age-matched controls. The women with fibroids had a low FSH level and a diminished FSH response to GnRH but an excessive PRL response to TRH while the other patient groups did not differ from the controls. The results indicate no relation between pituitary function and endometrial or ovarian tumor.
对17例子宫内膜癌患者、15例子宫肌瘤患者、11例卵巢囊腺瘤或卵巢癌患者以及14例年龄匹配的对照者，在促性腺激素释放激素（GnRH）和促甲状腺激素释放激素（TRH）刺激前后，测定血清促卵泡生成素（FSH）、促黄体生成素（LH）和催乳素（PRL）水平。子宫肌瘤患者的FSH水平较低，对GnRH的FSH反应减弱，但对TRH的PRL反应过度，而其他患者组与对照组无差异。结果表明垂体功能与子宫内膜或卵巢肿瘤之间无关联。
Zotero 插件